Standardized Dialysis for Acute Kidney Injury
(Recover-AKI Trial)
Trial Summary
What is the purpose of this trial?
This trial aims to test if using a consistent method for performing dialysis is feasible compared to letting each patient's kidney doctor decide the treatment specifics. The study focuses on patients with Acute Kidney Injury who are already receiving dialysis. The goal is to see if a standardized approach can improve care or make it easier to manage.
Research Team
Samuel A Silver
Principal Investigator
Queen's University
Eligibility Criteria
This trial is for patients who have had acute kidney injury and received at least two dialysis sessions, with plans to continue. It's not for those on dialysis for over 90 days, with certain pre-existing conditions like severe chronic kidney disease or specific acute renal diseases, recent kidney transplant recipients, or pregnant individuals.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a standardized dialysis strategy or usual care as prescribed by their primary nephrologist
Follow-up
Participants are monitored for safety and effectiveness after treatment, including dialysis-free days and hypotensive events
Treatment Details
Interventions
- Standardized Dialysis and Structured Discontinuation (S2D2)
- Usual Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Samuel Silver
Lead Sponsor
Samuel Silver
Lead Sponsor
Unity Health Toronto
Collaborator